Strategy

News

Fresenius' new CEO starts strategic review as pressure rises

When Michael Sen took over as chief executive of Fresenius at the start of this month, he knew he was facing some big challenges.

News

Rebranded Servier eyes €3bn in cancer drug sales by 2030

Servier is already in the process of transforming itself into a much bigger player in cancer, and has just tripled its sales objectives for the category.

News

Revamped Novartis highlights top R&D programmes at managemen...

With a reorganisation of Novartis now nearing completion, the Swiss pharma group is laying out its plans for growth at a meeting with investors and analysts, which it says will be driven ma

News

Roche CEO Severin Schwan to stand down after 14 years

Long-serving Roche chief executive Severin Schwan is stepping down, to be replaced next March by Thomas Schinecker, currently head of diagnostics at the Swiss group.

Partner Content